Literature DB >> 21414385

Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra.

Anthony P Nicholas1.   

Abstract

Deimination is a post-translational modification of proteins in which selected arginine amino acids are enzymatically converted to citrullines. Using dual-color immunofluorescence and an established monoclonal antibody (F95) against peptidyl-citrulline moieties, the present study is the first to compare immunohistochemical staining patterns for deiminated proteins in human substantia nigra (SN) from patients with Parkinson disease (PD) versus similar control specimens supplied by the Harvard Brain Bank. In control SN sections, many tyrosine hydroxylase (TH)-immunoreactive dopamine neurons were seen surrounded either by small fibers immunoreactive for deiminated proteins, or large reactive astrocytes, co-localized with glial fibrillary acidic protein (GFAP). However, in SN specimens from PD patients, immunoreactivity for deiminated proteins was also demonstrated within the cytoplasm of many surviving dopamine neurons that were also immunoreactive for TH, but this staining was not specifically restricted to Lewy bodies. Although the identity of neuronal deiminated proteins in these SN dopamine neurons is unknown, the present study provides evidence that the anatomical expression of these proteins in PD is altered and thus suggests that deimination may be involved in the pathophysiology of this disease.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414385     DOI: 10.1016/j.neulet.2011.03.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  The Rheumatoid Arthritis-Associated Citrullinome.

Authors:  Ronak Tilvawala; Son Hong Nguyen; Aaron J Maurais; Venkatesh V Nemmara; Mitesh Nagar; Ari J Salinger; Sunil Nagpal; Eranthie Weerapana; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2018-04-05       Impact factor: 8.116

Review 2.  Peptidyl arginine deiminases: detection and functional analysis of protein citrullination.

Authors:  Ronak Tilvawala; Paul R Thompson
Journal:  Curr Opin Struct Biol       Date:  2019-03-01       Impact factor: 6.809

Review 3.  Detection and identification of protein citrullination in complex biological systems.

Authors:  Kathleen W Clancy; Eranthie Weerapana; Paul R Thompson
Journal:  Curr Opin Chem Biol       Date:  2015-10-27       Impact factor: 8.822

Review 4.  Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.

Authors:  Byungki Jang; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Prion       Date:  2012-09-28       Impact factor: 3.931

5.  Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).

Authors:  Vera L Bonilha; Karen G Shadrach; Mary E Rayborn; Yong Li; Gayle J T Pauer; Stephanie A Hagstrom; Sanjoy K Bhattacharya; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2013-04-03       Impact factor: 3.467

6.  Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex.

Authors:  Anthony P Nicholas
Journal:  Neurosci Lett       Date:  2013-05-03       Impact factor: 3.046

7.  Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.

Authors:  Pei-Chen Hsu; Ya-Fan Liao; Chin-Li Lin; Wen-Hao Lin; Guang-Yaw Liu; Hui-Chih Hung
Journal:  Mol Cells       Date:  2014-05-22       Impact factor: 5.034

Review 8.  Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?

Authors:  Sigrun Lange; Mark Gallagher; Sharad Kholia; Uchini S Kosgodage; Mariya Hristova; John Hardy; Jameel M Inal
Journal:  Int J Mol Sci       Date:  2017-06-05       Impact factor: 5.923

Review 9.  Implications of DNA Methylation in Parkinson's Disease.

Authors:  Ernesto Miranda-Morales; Karin Meier; Ada Sandoval-Carrillo; José Salas-Pacheco; Paola Vázquez-Cárdenas; Oscar Arias-Carrión
Journal:  Front Mol Neurosci       Date:  2017-07-18       Impact factor: 5.639

10.  Minimotifs dysfunction is pervasive in neurodegenerative disorders.

Authors:  Surbhi Sharma; Richard J Young; Jingchun Chen; Xiangning Chen; Edwin C Oh; Martin R Schiller
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.